ATS Hosts 2023 Institutional Investor Day
- ATS had a ROIC of 12.7% for the period ended March 31, 2023.
- Deferred development additions for fiscal 2023 were $18.1 million.
- Research expenditures for fiscal 2023 totaled $9.3 million.
- Reoccurring revenue accounts for 25-35% of total revenues.
- Custom integration revenues represented 44% of fiscal 2023 revenues.
- Equipment/products revenues represented 29% of fiscal 2023 revenues.
- Services revenues represented 27% of fiscal 2023 revenues.
- None.
As part of management's presentations, the Company will provide additional non-IFRS financial measures and supplementary financial measures for use by investors in understanding the Company and its performance beyond existing disclosures in the Company's most recently filed public documents. Details with respect to these non-IFRS financial measures and supplementary financial measures are set out below. Management believes these non-IFRS financial measures and supplementary financial measures are useful to investors and plans to disclose going forward.
Return on invested capital ("ROIC")
ROIC is a measure of the efficiency of capital deployment. For ATS, ROIC is calcuated as follows: tax effected EBIT for return on invested capital 1 divided by Average Invested Capital 2 and for the period ended March 31, 2023, was
____________________________ |
1 EBIT for return on invested capital is a non-IFRS financial measure. See "Non-IFRS and Other Financial Measures" and "Reconciliation of Non-IFRS Measures to IFRS Measures" below. |
2 Average Invested Capital is a non-IFRS financial measure. See "Non-IFRS and Other Financial Measures" and "Reconciliation of Non-IFRS Measures to IFRS Measures" below. |
Innovation deferred development additions and research expenditures
In addition to deferred development additions, which are currently disclosed annually, the Company will disclose research expenditures which are grouped in cost of revenues on the Company's Consolidated and Interim Statements of Income. Deferred development additions for fiscal 2023 were
Research expenditures are expenditures related to research or development of new technologies or products, and are a component of cost of revenues on the Company's Consolidated and Interim Statements of Income.
Reoccurring revenue
Reoccurring revenue for ATS is defined as revenue from ancillary products and services associated with equipment sales and revenue from customers who purchase non-customized ATS products at regular intervals. Management estimates that reoccurring revenues are in the range of 25
Revenue disaggregation – Custom Integration, Equipment / Products, Services
Additional revenue disclosure is expected to assist investors in understanding the evolution of ATS' portfolio over time. Custom integration revenues for ATS includes end-to-end manufacturing solutions customized to customer needs and represented
ATS Corporation is an industry-leading automation solutions provider to many of the world's most successful companies. ATS uses its extensive knowledge base and global capabilities in custom automation, repeat automation, automation products and value-added services including pre-automation and after-sales services, to address the sophisticated manufacturing automation systems and service needs of multinational customers in markets such as life sciences, food & beverage, transportation, consumer products, and energy. Founded in 1978, ATS employs over 6,500 people at more than 60 manufacturing facilities and over 80 offices in
Throughout this press release management uses certain non-IFRS financial measures, non-IFRS ratios and supplementary financial measures to evaluate the performance of the Company. The terms "EBIT for return on invested capital", and "Average Invested Capital" are non-IFRS financial measures, "return on invested capital" or "ROIC", is a non-IFRS ratio, and "reoccurring revenues", "custom integration revenues", "equipment / products revenues", "service including spare parts revenues", and "research expenditures" are supplementary financial measures, all of which do not have any standardized meaning prescribed within International Financial Reporting Standards ("IFRS") and therefore may not be comparable to similar measures presented by other companies. Such measures should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. Reoccurring revenue for ATS is defined as revenue from ancillary products and services associated with equipment sales and revenue from customers who purchase non-customized ATS products at regular intervals. Custom integration revenues are defined as revenues from end-to-end manufacturing solutions customized to customer needs. Equipment / products revenues are defined as revenues from modular or standardized equipment and other products. Services including spare parts revenues are defined as revenues from consulting, digital and other services, including aftermarket services and spares. Return on invested capital is defined as the ratio between tax effected EBIT for return on invested capital and average invested capital. EBIT for return on invested capital is defined as the sum of net income, tax expense, interest expense, amortization of acquired intangible assets and restructuring charges. The most directly comparable IFRS financial measure to EBIT for return on invested capital is earnings from operations. Average invested capital is the average quarter end total of bank indebtedness, debt, and shareholders' equity, less cash for the prior four quarters. Research expenditures are defined as expenditures related to research or development of new technologies or products, and are a component of cost of revenues on the Company's Consolidated and Interim Statements of Income. Reoccurring revenues, custom integration revenues, equipment / products revenues and service including spare parts revenues are used by the Company to understand the revenue portfolio of the Company. Return on invested capital is used in measuring the efficiency of the Company's capital deployment. Research expenditures are used by the Company to assess investment in innovation. Management believes that ATS shareholders and potential investors in ATS use these additional IFRS measures and non-IFRS financial measures in making investment decisions and measuring operational results.
(C$ mm) | F2023 |
Adjusted earnings from operations | 343.4 |
Acquisition-related transaction costs | 3.1 |
Acquisition-related inventory fair value charges | 9.2 |
Mark to market portion of stock-based compensation | 13.4 |
Earnings from operations for ROIC purposes | 317.7 |
Restructuring charges | 27.5 |
Amortization of acquisition-related intangible assets | 67.7 |
Earnings from operations | 222.5 |
(C$ mm) | Q4 F22 | Q1 F23 | Q2 F23 | Q3 F23 | Q4 F23 |
Bank indebtedness | 1.8 | 2.7 | 17.9 | 12.0 | 5.8 |
Current portion of long-term debt | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 |
Long-term debt | 1,016.7 | 1,087.1 | 1,174.7 | 1,305.9 | 1,155.7 |
Shareholders' equity | 985.7 | 988.5 | 1,007.3 | 1,081.8 | 1,130.6 |
Cash and cash equivalents | (135.3) | (139.9) | (95.2) | (302.1) | (159.9) |
Invested capital | 1,868.9 | 1,938.5 | 2,104.7 | 2,097.6 | 2,132.3 |
Average invested capital | 2,028.4 |
(C$ mm) | F2023 |
Earnings from operations for ROIC purposes | 317.7 |
Average effective tax rate | 19.19 % |
Tax effected earnings from operations for ROIC purposes | 256.7 |
Average invested capital | 2,028.4 |
Return on invested capital | 12.7 % |
View original content to download multimedia:https://www.prnewswire.com/news-releases/ats-hosts-2023-institutional-investor-day-301919071.html
SOURCE ATS Corporation
FAQ
What additional details did ATS provide regarding its Institutional Investor Day?
What was ATS's ROIC for the period ended March 31, 2023?
What were the deferred development additions for fiscal 2023?
What were the research expenditures for fiscal 2023?
What percentage of total revenues does reoccurring revenue account for?
What percentage of fiscal 2023 revenues did custom integration represent?
What percentage of fiscal 2023 revenues did equipment/products represent?